Nexviazyme^{^®}
(avalglucosidase alfa)
Resources

Nexviazyme Resources for Healthcare Professionals

Below are some useful resources to guide you when starting your patients on Nexviazyme.

Prescribing Information

Nexviazyme Product Information - Full Product Information for Nexviazyme (avalglucosidase alfa).
Nexviazyme Preparation and Administration Guide (PDF) - A step-by-step guide on preparing and administering Nexviazyme.

Safety Information

Nexviazyme Immunotesting Services Guide (PDF) - Information on immunology testing services provided with Nexviazyme administration.
Nexviazyme Home Infusion Guide (PDF) - A guide for healthcare professionals with patients being treated via home infusion therapy.

Clinical Resources

How to Start Nexviazyme (PDF) - How to start your patients on Nexviazyme and manage ongoing therapy.
Nexviazyme Healthcare Professionals FAQ Guide (PDF) - Frequently asked questions for healthcare professionals prescribing Nexviazyme.
Nexviazyme Pharmacist Guide (PDF) - A practical guide to Nexviazyme for pharmacists.
Nexviazyme Mechanism of Action (Video) - Learn how the absence of GAA impairs patients with Pompe disease.
Nexviazyme In-Service (PDF) - A practical guide to Nexviazyme administration for healthcare professionals.

Home Infusion Resources

Care for Rare Home Infusion Program (PDF) - Provides an overview of the Care for Rare Home Infusion Program.
Care for Rare Home Infusion Program (Video) - A resource for patients with Pompe disease to learn more about the Care for Rare Home Infusion Program.
Home Infusion Guide for Healthcare Professionals (PDF) - Outlines the process for patient evaluation, selection and enrolment.

Patient Support

Nexviazyme Patient FAQ Guide (PDF) - Frequently asked questions for patients with Pompe disease.
Pompe disease and Nexviazyme Brochure (PDF) - Patient information about Pompe disease and their treatment when prescribed Nexviazyme.

PBS Information: NEXVIAZYME. This product is not listed on the PBS. This product is funded under the Life Saving Drugs Program.

Please review full Nexviazyme Product Information before prescribing. Full Product Information is available from sanofi-aventis australia pty ltd here or by contacting 1800 818 806.

▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Nexviazyme^® is a registered trademarks of Sanofi.

MAT-AU-2202546 - 2.0 - 05/2024